Sowell Financial Services’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $343K | Sell |
5,256
-6
| -0.1% | -$392 | 0.01% | 731 |
|
|
2025
Q1 | $352K | Buy |
+5,262
| New | +$352K | 0.02% | 698 |
|
|
2023
Q2 | – | Sell |
-5,926
| Closed | -$235K | – | 567 |
|
|
2023
Q1 | $235K | Buy |
+5,926
| New | +$235K | 0.02% | 645 |
|
|
2021
Q2 | – | Sell |
-6,229
| Closed | -$218K | – | 618 |
|
|
2021
Q1 | $218K | Buy |
6,229
+6,226
| +207,533% | +$218K | 0.01% | 1003 |
|
|
2020
Q4 | $0 | Hold |
3
| – | – | ﹤0.01% | 2682 |
|
|
2020
Q3 | $0 | Sell |
3
-1,229
| -100% | – | ﹤0.01% | 2510 |
|
|
2020
Q2 | $40K | Hold |
1,232
| – | – | ﹤0.01% | 1227 |
|
|
2020
Q1 | $50K | Buy |
1,232
+1,224
| +15,300% | +$49.7K | ﹤0.01% | 1057 |
|
|
2019
Q4 | $0 | Hold |
8
| – | – | ﹤0.01% | 2504 |
|
|
2019
Q3 | $1K | Buy |
+8
| New | +$1K | ﹤0.01% | 2183 |
|
|
2017
Q1 | – | Sell |
-8
| Closed | -$1K | – | 268 |
|
|
2016
Q4 | $1K | Buy |
+8
| New | +$1K | ﹤0.01% | 605 |
|